Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2023
Immunology and Microbiology journal rankings 2023
132 ranked journals · Field in Life Sciences
Immunology and Microbiology has 132 ranked journals in 2023. The median journal has an OJR of 0.85, below the world average of 1.00, up 0.01 on 2022; Q1 starts at OJR 1.25. The top three are Immunity, Nature Immunology, and Nature reviews. Immunology.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences132 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.26Q1 | 18.69 4.94 down from 2022 | 708 | 100% | $10,400 | ||
2Nature ImmunologyNature Portfolio · United States | 4.65Q1 | 16.88 2.88 down from 2022 | 698 | 55% | $12,690 | ||
3Nature reviews. ImmunologyNature Portfolio · United Kingdom | 4.31Q1 | 26.81 7.52 down from 2022 | 537 | 32% | — | ||
4Science ImmunologyAmerican Association for the Advancement of Science · United States | 4.27Q1 | 16.04 5.31 down from 2022 | 494 | 64% | — | ||
5Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 3.64Q1 | 10.35 0.18 down from 2022 | 171 | 39% | $5,490 | ||
6Journal of AutoimmunityElsevier BV · United Kingdom | 3.53Q1 | 9.39 7.48 down from 2022 | 337 | 67% | $5,420 | ||
7Cellular and Molecular ImmunologySpringer Nature · China | 3.45Q1 | 12.62 2.47 down from 2022 | 587 | 100% | $5,190 | ||
8Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.27Q1 | 8.51 1.89 down from 2022 | 188 | 81% | $3,790 | ||
9The Journal of Experimental MedicineRockefeller University Press · United States | 3.18Q1 | 10.17 2.88 down from 2022 | 793 | 100% | — | ||
10Annual Review of ImmunologyAnnual Reviews · United States | 3.00Q1 | 29.18 3.82 down from 2022 | 84 | 96% | — | ||
11Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.86Q1 | 8.69 2.59 down from 2022 | 1,242 | 61% | $4,900 | ||
12Seminars in ImmunologyElsevier BV · United States | 2.29Q1 | 7.53 1.17 down from 2022 | 160 | 70% | $4,370 | ||
13Mucosal ImmunologyOAElsevier BV · United States | 2.18Q1 | 8.39 0.38 up from 2022 | 307 | 100% | $4,370 | ||
14Immunity & AgeingOABioMed Central · United Kingdom | 1.92Q1 | 5.73 3.45 down from 2022 | 145 | 100% | $3,190 | ||
15Frontiers in ImmunologyOAFrontiers Media · Switzerland | 1.90Q1 | 6.43 1.82 down from 2022 | 17,098 | 100% | $3,801 | ||
16Clinical ImmunologyElsevier BV · Netherlands | 1.61Q1 | 4.41 4.54 down from 2022 | 600 | 23% | $4,400 | ||
17BiologicsOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.61Q1 | 5.46 0.88 down from 2022 | 41 | 100% | $1,207 | ||
18BioDrugsAdis, Springer Healthcare · Switzerland | 1.60Q1 | 6.42 0.20 down from 2022 | 161 | 62% | $5,190 | ||
19Immune NetworkOASouth Korea | 1.56Q1 | 4.84 1.97 down from 2022 | 147 | 100% | — | ||
20Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.56Q1 | 4.93 2.49 down from 2022 | 358 | 32% | $4,790 | ||
21Genes and ImmunitySpringer Nature · United States | 1.55Q1 | 5.87 0.09 down from 2022 | 97 | 58% | $3,190 | ||
22Food and Waterborne ParasitologyOAElsevier BV · United States | 1.53Q1 | 3.70 0.40 up from 2022 | 81 | 100% | $2,500 | ||
23International Journal for ParasitologyElsevier BV · Australia | 1.51Q1 | 4.00 0.42 down from 2022 | 299 | 57% | $2,880 | ||
24ImmunologyWiley · United Kingdom | 1.43Q1 | 4.93 1.07 down from 2022 | 401 | 85% | $5,330 | ||
25Parasites & VectorsOABioMed Central · United Kingdom | 1.39Q1 | 3.69 0.14 down from 2022 | 1,695 | 100% | $3,090 | ||
26The AAPS JournalSpringer Science+Business Media · United States | 1.39Q1 | 5.75 0.83 up from 2022 | 352 | 48% | $5,090 | ||
27Clinical & Translational ImmunologyOAWiley · Australia | 1.37Q1 | 5.00 1.33 down from 2022 | 330 | 100% | $3,070 | ||
28Psoriasis Targets and TherapyOADove Medical Press · New Zealand | 1.30Q1 | 6.43 3.25 up from 2022 | 43 | 100% | $2,320 | ||
29Journal of Leukocyte BiologyOxford University Press · United States | 1.29Q1 | 3.55 2.19 down from 2022 | 634 | 73% | $3,800 | ||
30Current Research in Parasitology and Vector-Borne DiseasesOAElsevier BV · Netherlands | 1.29Q1 | 3.43 1.12 up from 2022 | 94 | 100% | $2,350 | ||
31International ImmunologyOxford University Press · United Kingdom | 1.27Q1 | 3.33 0.70 down from 2022 | 242 | 71% | $3,530 | ||
32Ticks and Tick-borne DiseasesOAElsevier BV · Germany | 1.26Q1 | 3.32 0.05 up from 2022 | 597 | 100% | $3,010 | ||
33Trends in ImmunologyElsevier BV · United Kingdom | 1.25Q1 | 7.28 2.88 down from 2022 | 405 | 64% | $7,030 | ||
34Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.24Q2 | 4.49 0.28 up from 2022 | 122 | 100% | $3,590 | ||
35Immunotherapy AdvancesOAOxford University Press · United Kingdom | 1.23Q2 | 4.65 1.25 up from 2022 | 59 | 100% | $3,053 | ||
36Immunologic ResearchSpringer Science+Business Media · United States | 1.21Q2 | 3.77 1.33 down from 2022 | 226 | 35% | $2,890 | ||
37Parasite Epidemiology and ControlOAElsevier BV · United Kingdom | 1.21Q2 | 2.74 1.16 down from 2022 | 130 | 100% | $1,800 | ||
38Drug Healthcare and Patient SafetyOADove Medical Press · New Zealand | 1.19Q2 | 3.50 1.16 up from 2022 | 78 | 100% | $2,320 | ||
39Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.18Q2 | 3.65 0.84 down from 2022 | 395 | 41% | — | ||
40Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.17Q2 | 10.94 4.81 down from 2022 | 168 | 46% | $4,900 | ||
41CytokineElsevier BV · United Kingdom | 1.14Q2 | 4.25 0.16 up from 2022 | 832 | 29% | $3,220 | ||
42ParasiteOAEDP Sciences · France | 1.14Q2 | 2.63 0.84 down from 2022 | 227 | 100% | $1,695 | ||
43Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.13Q2 | 3.71 0.56 down from 2022 | 400 | 100% | $3,816 | ||
44Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.12Q2 | 4.68 0.94 down from 2022 | 645 | 63% | $4,990 | ||
45Current Research in ImmunologyElsevier BV · Netherlands | 1.09Q2 | 3.94 1.70 up from 2022 | 54 | 100% | $2,520 | ||
46International Reviews of ImmunologyTaylor & Francis · United States | 1.07Q2 | 4.36 0.90 down from 2022 | 112 | 0% | — | ||
47Infection and ImmunityOAAmerican Society for Microbiology · United States | 1.07Q2 | 3.24 0.09 up from 2022 | 665 | 100% | — | ||
48Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.04Q2 | 2.58 0.89 down from 2022 | 112 | 100% | $3,490 | ||
49Immunology LettersElsevier BV · Netherlands | 1.03Q2 | 3.31 1.37 down from 2022 | 309 | 37% | $3,290 | ||
50Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 1.02Q2 | 4.46 0.54 down from 2022 | 1,757 | 16% | $4,330 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
36 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 132
- Window papers (baseline)
- 143,532 +13.1% from indicator year 2020
- Median OJR
- 0.854 -4.1% from indicator year 2020
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.